Steve E. Krognes - 09 Aug 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
Issuer symbol
GH
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
11 Aug 2022, 16:12:14 UTC
Previous filing
21 Jul 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Award $0 +7,405 $0.000000 7,405 09 Aug 2022 COMMON STOCK 7,405 $0.000000 Direct F1, F2
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +11,879 $0.000000 11,879 09 Aug 2022 COMMON STOCK 11,879 $48.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 9, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 9, 2023, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.
F3 The stock option vest as to 25% of the shares subject to such award on August 9, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on eachmonthly anniversary of August 9, 2023, during the three-year period thereafter.